Experience Counts: Unveiling Patients' Willingness to Pay for Remote Monitoring and Patient Self-Measurement

Abstract

Objectives: This study aimed to: (1) estimate patients’ willingness to pay (WTP) for remote monitoring (RM) and patient self-measurement (PSM) for pregnant women at risk of gestational hypertensive disorders (GHD), (2) assess the impact of experience with these technologies on WTP, and (3) determine their impact on Health-Related Quality of Life (HRQoL).

Methods: Data collection was part of a multicentric randomized controlled trial, Pregnancy REmote MOnitoring (“PREMOM”) II, with two interventions: RM and PSM. A contingent valuation survey, combining a payment card and open-ended question, was completed twice by 199 participants. Two-part models analyze the impact of experience on WTP, regression models estimated using Ordinary Least Squares the impact of RM and PSM on HRQoL.

Results: The mean WTP amount was approximately € 120 for RM and € 80 for PSM. Compared to having no experience, WTP RM was € 63 higher after a long-term exposure to RM (p-value: 0.01) and WTP PSM was € 26 lower after a short-term exposure to RM (p-value: 0.07). No significant impact of RM or PSM on HRQoL was found.

Conclusions: This study contributes to the discussion on the impact of experience on WTP. Those who had a long-term experience with RM, were willing to pay more for RM than those without experience. This confirms our hypothesis that involving patients without experience with the valued treatment, possibly underestimates WTP. A long-term experience has, however, no impact on the WTP for technologies for which the potential benefits are apparent without experiencing them, like PSM.